National Research Institute-Panorama City

Panorama City, California 91402

0 studies enrolling now · 7 studies all time

What they study most

NASH - Nonalcoholic Steatohepatitis, Non-Alcoholic Fatty Liver Disease, Pregnancy, Steatohepatitis, Nonalcoholic, Type 2 Diabetes

Studies at this site

• A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) — Running, not enrolling
• A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis — Running, not enrolling
• A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE) — Running, not enrolling
• A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224 — Completed
• A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients — Completed
• A Study of LY3437943 in Participants With Type 2 Diabetes — Completed
• Clinical Investigation for the Preview® hCG Urine/Serum Combo Pregnancy Test — Completed